Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Yet another international acknowledgement

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Aug 15, 2022 5:52pm

205 Views

Post# 34897779

RE:RE:RE:RE:Yet another international acknowledgement

ScienceFirst wrote:
1. FDA interim approvals (Breakthrough, Accelerated Approval) is the first step to establish seriousness and credibility.

2. AUA and ASCO conferences are additional medias to obtain visibility to specific specialists.

3. Big pharma's sales/marketing teams, once partnership is established and commercial FDA approval is granted, are the final tool.

_________________

Eoganacht - (8/15/2022 3:37:36 PM)

RE:RE:Yet another international acknowledgement

All these experts will help spread the word when convincing data finally arrives. It's one thing to get FDA approval, it's another thing for urological oncologists to recommend the treatment to their patients.